SCHEMBL1397155

SCHEMBL1397155

CC(=O)C(C)C(C)C(C)=O

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
TSHR P16473 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
THPO P40225 1/20 0.39
FFAR3 O14843 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
TP53 P04637 1/20 0.38
CA1 P00915 2/20 0.36
ALOX15 P16050 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12737240 1.00 LMNA (0.42) LMNATSHRALDH1A1TDP1THPO
SCHEMBL10570748 0.86 TP53 (0.44) TSHRALDH1A1TDP1FFAR3LCK
SCHEMBL172872 0.84
SCHEMBL12880101 0.84
SCHEMBL14123059 0.84 LMNA (0.36) LMNATSHRALDH1A1TDP1THPO
SCHEMBL270417 0.84
SCHEMBL12835744 0.83 ALDH1A1 (0.30) TSHRALDH1A1TDP1
SCHEMBL13717072 0.81
SCHEMBL18211452 0.81
SCHEMBL17860738 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618982-A SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES RHONE-POULENC CHIMIE (FR) 1997-04-08 US claimed
EP-4638148-A1 TIRES FOR VEHICLE WHEELS Pirelli Tyre S.p.A. (IT) 2025-10-29 EP disclosed
WO-2024134488-A1 TIRES FOR VEHICLE WHEELS PIRELLI TYRE S.P.A. (IT) 2024-06-27 WO disclosed
CN-111032671-B Protected tetraose, method for the production thereof and use thereof as a substrate for transglucosidase receptors in the chemoenzymatic synthesis of shigella flexneri-specific oligosaccharides 巴斯德研究所 2024-01-12 CN disclosed
US-20240002423-A1 PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE AS TRANSGLUCOSYLASE ACCEPTOR SUBSTRATES IN THE CHEMO-ENZYMATIC SYNTHESIS OF SHIGELLA FLEXNERI SPECIFIC OLIGOSACCHARIDES PASTEUR INSTITUT (FR) 2024-01-04 US disclosed
US-11834468-B2 Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific oligosaccharides INSTITUT PASTEUR (FR) 2023-12-05 US disclosed
US-20220118458-A1 HEAT TREATED PULSE FLOURS AHIMSA FOUNDATION, AS COLLATERAL AGENT 2022-04-21 US disclosed
CN-107849594-B Deamination of organophosphorus nucleosides 科技学专业学院有限公司 2022-01-18 CN disclosed
US-11116212-B2 Carbonyl containing compounds for controlling and repelling Cimicidae populations SEMIOSBIO TECHNOLOGIES INC. (CA) 2021-09-14 US disclosed
US-11116212-B2 Carbonyl containing compounds for controlling and repelling Cimicidae populations SEMIOSBIO TECHNOLOGIES INC. (CA) 2021-09-14 US disclosed
US-20030149152-A1 Rapid curing property, depth curability, and workability; for use as a sealing material for motor vehicles and buildings, industrial sealing material, adhesive, coating material, encapsulating or potting material for electrical/ electronic THREE BOND CO., LTD. (JP) 2003-08-07 US disclosed
WO-2003062241-A1 FUSED HETEROCYCLIC SUCCINIMIDECOMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-31 WO disclosed
EP-1319007-A1 FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION Bristol-Myers Squibb Company (US) 2003-06-18 EP disclosed
EP-1298169-A1 COLD-SETTING COMPOSITION THREE BOND CO., LTD. (JP) 2003-04-02 EP disclosed
WO-2002024702-A1 FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2002-03-28 WO disclosed
EP-0654460-B1 Process for the C-alkylation of a ketonic compound RHONE POULENC CHIMIE (FR) 1997-06-18 EP disclosed
US-5618982-A SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES RHONE-POULENC CHIMIE (FR) 1997-04-08 US disclosed
EP-0654460-A1 Process for the C-alkylation of a ketonic compound RHONE-POULENC CHIMIE (FR) 1995-05-24 EP disclosed
EP-0562624-A2 Stabilization of functional proteins Modrovich, Ivan E. (US) 1993-09-29 EP disclosed
US-4021566-A ANTISECRETORY, ANTIULCER STERLING DRUG INC. (US) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11834468-B2 Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific oligosaccharides SI, GALE, FUT5 LMNA 4034/4885TSHR 3916/4885ALDH1A1 1374/4885
US-20240002423-A1 PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE AS TRANSGLUCOSYLASE ACCEPTOR SUBSTRATES IN THE CHEMO-ENZYMATIC SYNTHESIS OF SHIGELLA FLEXNERI SPECIFIC OLIGOSACCHARIDES SI, GALE, FUT5 LMNA 4034/4885TSHR 3916/4885ALDH1A1 1374/4885
US-11116212-B2 Carbonyl containing compounds for controlling and repelling Cimicidae populations DDT, AOC1, EGLN1 LMNA 4155/4885TSHR 4777/4885ALDH1A1 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.